Gilead Sciences Inc
NASDAQ: GILD
$83.94
+$0.04 (+0.0%)
Closing Price on September 20, 2024
GILD Articles
The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels, Lockheed Martin and Rite Aid.
Published:
Last Updated:
24/7 Wall St. is taking a look at the bottom line for companies in the S&P 500 going into 2016, and we have chosen some of the least expensive stocks for the year.
Published:
Last Updated:
The short interest data are out for the December 15 settlement date, and short interest continued to be mixed in these selected biotech stocks.
Published:
Last Updated:
New data suggests that the stock market's performance in 2015 was bolstered or supported by the largest S&P 500 companies buying back their own stock.
Published:
Last Updated:
Amgen is getting aggressive enough on its dividend payout that you might think the biotech giant is now just a Big Pharma stock.
Published:
Last Updated:
Over the past 10 years the single, most innovative company in the world has been Apple, according to the Boston Consulting Group.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous report, and short interest was mixed in these selected stocks for this settlement date.
Published:
Last Updated:
24/7 Wall St. has reviewed the short interest data on the top biotech companies.
Published:
Last Updated:
Here are 10 stocks that could outperform the index funds from now to early February.
Published:
Last Updated:
Merck is joining the likes of Gilead Sciences in producing hepatitis C vaccines, but it is still in the early clinical stages.
Published:
Last Updated:
The short interest data are out for the October 30 settlement date, and short interest fell in selected biotech stocks.
Published:
Last Updated:
24/7 Wall St. has collected several big FDA decisions coming up in the month of November.
Published:
Last Updated:
Gilead Sciences reported its third-quarter financial results after the markets closed on Tuesday.
Published:
Last Updated:
Gilead Sciences is set to report its third-quarter financial results after the markets close on Thursday.
Published:
The October 15 short interest data have been compared with the previous figures, and short interest mixed in these selected biotech stocks.
Published: